Evidence map›Paper›PMID 41163053›Full record

ArticleBreast cancer research : BCR2025

Lifestyle changes and postmenopausal breast cancer risk in women from the European Prospective Investigation into Cancer and Nutrition.

Fanélie Vasson, Komodo Matta, Carine Biessy, Christian S Antoniussen, Agnès Fournier, Chloé Marques, Claire Cadeau, Charlotte Le Cornet, Renée T Fortner, Matthias B Schulze and 18 more

Abstract read
In one paragraph

Article in Breast cancer research : BCR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Fanélie VassonNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Komodo MattaNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Carine BiessyNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Christian S AntoniussenDepartment of Public Health, Aarhus University, Aarhus, Denmark.
Agnès FournierParis-Saclay University, UVSQ, Inserm, Gustave Roussy, CESP, Villejuif, France.
Chloé MarquesParis-Saclay University, UVSQ, Inserm, Gustave Roussy, CESP, Villejuif, France.
Claire CadeauParis-Saclay University, UVSQ, Inserm, Gustave Roussy, CESP, Villejuif, France.
Charlotte Le CornetDivision of Cancer Epidemiology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
Renée T FortnerDivision of Cancer Epidemiology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.
Sabina SieriEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Salvatore PanicoSchool of Medicine, Federico II University, Naples, Italy.
Rosario TuminoHyblean Association for Epidemiological Research, AIRE-ONLUS, Ragusa, Italy.
Fulvio RicceriDepartment of Clinical and Biological Sciences, Centre for Biostatistics, Epidemiology, and Public Health (C-BEPH), University of Turin, Turin, Italy.
Giovanna MasalaInstitute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Anouk E HienschJulius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Evelyn M MonninkhofJulius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Antonio AgudoUnit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, 08908, L'Hospitalet de Llobregat, Spain.
Marcela GuevaraInstituto de Salud Pública y Laboral de Navarra, 31003, Pamplona, Spain.
Sandra M Colorado-YoharCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain.
Maria-José SánchezCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain.
Adrian LlorenteSub Directorate for Public Health and Addictions of Gipuzkoa, Ministry of Health of the Basque Government, San Sebastián, Spain.
Sandar Tin TinCancer Epidemiology Unit, Oxford Population Health, University of Oxford, Oxford, UK.
Isobel G JacksonDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Marc J GunterDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Edoardo BotteriDepartment of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.
Pietro FerrariNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Laure DossusNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France. dossusl@iarc.who.int.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundThe risk of breast cancer has been associated with various lifestyle factors, yet the evidence regarding how lifestyle modifications affect this risk remains limited. This study examines the relationship between changes in the Healthy Lifestyle Index (HLI) and postmenopausal breast cancer risk in women participating in the European Prospective Investigation into Cancer (EPIC).

methodsHLI scores (ranging from 0 to 16) were computed based on smoking habits, alcohol consumption, body mass index (BMI), and physical activity levels, using data from baseline and follow-up questionnaires, which were separated by a median interval of 10  (IQR: 5.2-12.0) years. Among the 125,746 women included in the analyses, 2,175 developed breast cancer over a median follow-up period of nearly 4  (IQR: 2.9-8.4) years starting from the date of the second lifestyle questionnaire. Cox proportional hazards models were employed to estimate hazard ratios (HRs) and confidence intervals (CIs) for the relationship between changes in HLI and postmenopausal breast cancer risk, analysed both overall and by estrogen receptor (ER) status. Individual components of the HLI were also analysed, with sensitivity analyses addressing potential reverse causation by delaying the start of follow-up by 1 to 3 years.

resultsEach unit increase in the HLI-reflecting a healthier lifestyle-was not associated with the overall risk of postmenopausal breast cancer. Among individual components, only a one-unit increase in the BMI score, corresponding to a shift towards a healthier BMI, was inversely associated with overall (HR = 0.936; 95% CI 0.880-0.996) and ER-positive (HR = 0.930; 95% CI 0.865-1.000) postmenopausal breast cancer risks.

conclusionsLifestyle changes, as measured by the HLI, during mid-adulthood were not significantly associated with the risk of postmenopausal breast cancer. More specifically, the results of this study suggested that a shift towards a healthier BMI may contribute to breast cancer prevention. Further research involving diverse and larger study populations and lifestyle assessments at earlier life stages could provide deeper insights.

Indexed as

Breast NeoplasmsLife StylePostmenopauseAgedBody Mass IndexEuropeExerciseFemaleFollow-Up StudiesHumansMiddle AgedProportional Hazards ModelsProspective StudiesReceptors, EstrogenRisk FactorsSurveys and QuestionnairesReceptors, EstrogenBreast cancerHealthy lifestyle indexLifestyle changesLongitudinalProspective cohortRisk

Identifiers

PMID41163053
PMCPMC12574052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.